Tick-borne disease

American Family Physician

Volumn 71, Issue 12, 2005, Pages 2323-2332

  Bratton, Robert L ^a,c   Corey, G Ralph ^b  

^a MAYO CLINIC   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFUROXIME; CEFUROXIME AXETIL; CHLORAMPHENICOL; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; QUININE; QUININE SULFATE; STREPTOMYCIN; TETRACYCLINE;

ADULT; BABESIOSIS; BORRELIA INFECTION; CHILD; CLINICAL FEATURE; COLORADO TICK FEVER; DIAGNOSTIC ACCURACY; EHRLICHIOSIS; ERYTHEMA CHRONICUM MIGRANS; FLU LIKE SYNDROME; GENERAL PRACTITIONER; HERXHEIMER REACTION; HUMAN; LYME DISEASE; MORBIDITY; MORTALITY; RASH; REVIEW; ROCKY MOUNTAIN SPOTTED FEVER; SYMPTOM; TICK BITE; TICK BORNE DISEASE; TULAREMIA; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; ARACHNID VECTORS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; PRIMARY HEALTH CARE; TICK-BORNE DISEASES; TICKS; UNITED STATES;

EID: 21044457133     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Gayle A, Ringdahl E. Tick-borne diseases. Am Fam Physician 2001; 64:461-6.
2. Byrd RP Jr, Vasquez J, Roy TM. Respiratory manifestations of tick-borne diseases in the Southeastern United States. South Med J 1997;90:1-4.
3. Beers MH, Berkow R. The Merck manual of diagnosis and therapy. 17th ed. Whitehouse Station, N.J.: Merck Research Laboratories, 1999.
4. Walker DH. Tick-transmitted infectious diseases in the United States. Annu Rev Public Health 1998;19:237-69.
5. Drage LA. Life-threatening rashes: dermatologic signs of four infectious diseases. Mayo Clin Proc 1999;74:68-72.
6. Kwitkowski VE, Demko SG. Infectious disease emergencies in primary care. Lippincotts Prim Care Pract 1999;3:108-25
7. Centers for Disease Control and Prevention. Rocky Mountain spotted fever. Accessed online April 11, 2005, at: http://www.cdc.gov/ncidod/ dvrd/rmsf/index.htm.
8. Sleeve AC. Lyme borreliosis. In: Kasper DL Harrison TR. Harrison's Manual of medicine. 16th ed. New York: McGraw-Hill, 2005:995-9.
9. Shapiro ED. Tick-borne diseases. Adv Pediatr Infect Dis 1997;13:187-218.
10. Thorner AR, Walker DH, Petri WA Jr. Rocky Mountain spotted fever. Clin Infect Dis 1998;27:1353-9.
11. Black-legged tick. Accessed online April 11, 2005, at: http://www. enature.com/fieldguide/showSpecies_LI.asp?imageID=18509.
12. Piesman J, Mather TN, Sinsky RJ, Spielman A. Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol 1987;25:557-8.
13. Piesman J, Maupin GO, Campos EG, Happ CM. Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, with description of a needle aspiration isolation method. J Infect Dis 1991;163:895-7.
14. Piesman J. Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. J Infect Dis 1993;167:1082-5.
15. Falco RC, Fish D, Piesman J. Duration of tick bites in a Lyme disease-endemic area. Am J Epidemiol 1996;143:187-92.
16. Centers for Disease Control and Prevention Lyme disease. Accessed online April 11, 2005, at: http://www.cdc.gov/ncidod/dvbid/lyme/ index.htm.
17. Magid D, Schwartz B, Craft J, Schwartz JS. Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med 1992;327:534-41.
18. Treatment of Lyme disease. Med Lett Drugs Ther 2000;42:37-9.
19. Belman AL. Tick-borne diseases. Semin Pediatr Neurol 1999;6:249-66.
20. Centers for Disease Control and Prevention. Human ehrlichiosis in the United States. Accessed online April 11, 2005, at: http://www.cdc. gov/ncidod/dvrd/ehrlichia/index.htm.
21. Evans ME, Gregory DW, Schaffner W, McGee ZA. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 1985;64:251-69.
22. Miller RP, Bates JH. Pleuropulmonary tularemia. A review of 29 patients. Am Rev Respir Dis 1969;99:31-41.
23. Rubin SA. Radiographic spectrum of pleuropulmonary tularemia. AJR Am J Roentgenol 1978;131:277-81.
24. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001;285:2763-73.
25. Drugs for parasitic infections. Med Lett Drugs Ther 2004. Accessed online April 11, 2005, at: http://www.medletter.com/freedocs/parasitic.pdf.
26. Emmons RW. An overview of Colorado tick fever. Prog Clin Biol Res 1985;178:47-52.
27. Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA. The Sanford guide to antimicrobial therapy. 34th ed. Hyde Park, Vt.: Antimicrobial Therapy, 2004:39.
28. Walker DH, Barbour AG, Oliver JH, Lane RS, Dumler JS, Dennis DT, et al. Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA 1996;275:463-9.
29. Meldrum SC, Birkhead GS, White DJ, Benach JL, Morse DL. Human babesiosis in New York state: an epidemiological description of 136 cases. Clin Infect Dis 1992;15:1019-23.
30. Gammons M, Salam G. Tick removal. Am Fam Physician 2002;66:643-5.